10x Genomics, Inc. TXG revenue by segment, product and geography
In its fiscal year ending 2025-12-31, 10x Genomics, Inc. reported revenue across 9 products and services; the largest, Product And Service Revenue, was $597M (-2.3% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product And Service Revenue$597Mshare n/a-2.3% yoy
- Consumables$507Mshare n/a+2.8% yoy
- Single Cell Consumables$363Mshare n/a-2.4% yoy
- Spatial Consumables$144Mshare n/a+18.9% yoy
- Instruments$56.8Mshare n/a-38.8% yoy
- Licensing And Royalty Revenue$46.1Mshare n/a+14272.3% yoy
- Spatial Instruments$34.1Mshare n/a-40.7% yoy
- Service$32.7Mshare n/a+34.6% yoy
- +1 more member in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Americas$359Mshare n/a+3.2% yoy
- United States$347Mshare n/a+3.6% yoy
- EMEA$162Mshare n/a+1.2% yoy
- Asia Pacific$122Mshare n/a+18.5% yoy
- China$70.3Mshare n/a+22.6% yoy
- Asia Pacific Excluding China$52.1Mshare n/a+13.3% yoy
- Americas Excluding United States$12.3Mshare n/a-8.8% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Product And Service Revenue$150Mshare n/a+8.8% yoy
- Consumables$130Mshare n/a+12.5% yoy
- Chromium Consumables$88.9Mshare n/a+5.7% yoy
- Spatial Consumables$40.9Mshare n/a+30.9% yoy
- Instruments$11.3Mshare n/a-24.0% yoy
- Service$8.83Mshare n/a+15.4% yoy
- +3 more members in the filing
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.